Startups developing a technology to speed up drug discovery, a service to manage complex health data, a digital therapy for menstrual disorders, solutions to enable remote work abroad, and adaptive solar façades each win CHF 10,000
Summary
IsoSpec Analytics is a bioanalytical technology spin-off from the Ecole Polyt\xe9chnique F\xe9d\xe9rale de Lausanne (EPFL) that aims at reducing failure rates for drugs in fields including oncology and neurodegenerative diseases by providing key information during target validation and compound screening. The team composed of Founders Arne Wehling and Tobias Kull, PhDs from the ETH Zurich, see themselves as a link between the numerous hospital information and medical practice management systems. Their digital therapy helps women to create healthy menstrual cycles without artificial hormones or drugs, with lifestyle interventions provided through an online course and community video calls. Companies now want to offer temporary remote work abroad to employees as an official benefit, in order to attract and retain top talent - but they struggle to get a handle on the legal and business risks, as well as the extra workload. Additionally, those would require additional cooling and shading systems, further increasing cost and energy consumption.Zurich Soft Robotics offers its multifunctional Adaptive Solar Facade (ASF), a second building skin that solves both problems: The ASF increases the PV generation by up to 40% due to active solar tracking and the AI-controlled shading capabilities reduce the building cooling energy demand by 20-80% compared to traditional systems while improving occupants comfort and well-being.